Sometimes Washington triggers a stock move that can hand us outsized gains. That's exactly what happened with Gilead Sciences Inc. (Nasdaq: GILD)....
Today we're taking a look at four of your most perceptive investing questions. We also answer an inquiry from Stuart Varney.
After all,...
There's a lot of money to be made in the mergers and acquisitions (M&A) market. And we expect to see a lot more through the end of the...
Gilead Sciences Inc. (Nasdaq: GILD) is facing criticism again this week for its highly priced Hepatitis C drug Sovaldi. The...
For weeks now biotech stocks have headlined our list of top stocks to invest in for 2015.
And a particular biotech ETF is showing...
Today I want to reintroduce you to a biotech stock that Wall Street has been pricing as though it were dead money.
This biotech company...
Gilead Sciences Inc. (Nasdaq: GILD) stock hit a 52-week high of $92.97 this morning (Thursday) after the company crushed...
Market volatility has suddenly created some great opportunities, including those in the biotech sector.
Supporting the inevitable ...
Now that all the key deadlines for Obamacare have finally taken effect, a lot of tech investors are busy trying to figure out how this will...
